186 related articles for article (PubMed ID: 8106229)
41. Frequency of isolation and antimicrobial susceptibility of bacteria isolated from bloodstream infections at Children's Medical Center, Tehran, Iran, 1996-2000.
Mamishi S; Pourakbari B; Ashtiani MH; Hashemi FB
Int J Antimicrob Agents; 2005 Nov; 26(5):373-9. PubMed ID: 16213124
[TBL] [Abstract][Full Text] [Related]
42. Challenges in the treatment of infections caused by gram-positive and gram-negative bacteria in patients with cancer and neutropenia.
Rolston KV
Clin Infect Dis; 2005 Apr; 40 Suppl 4():S246-52. PubMed ID: 15768330
[TBL] [Abstract][Full Text] [Related]
43. Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series.
Pastewski AA; Caruso P; Parris AR; Dizon R; Kopec R; Sharma S; Mayer S; Ghitan M; Chapnick EK
Ann Pharmacother; 2008 Sep; 42(9):1177-87. PubMed ID: 18664609
[TBL] [Abstract][Full Text] [Related]
44. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
[TBL] [Abstract][Full Text] [Related]
45. Invasive bacterial infections in a pediatric oncology unit in a tertiary care center.
Trehan A; Totadri S; Gautam V; Bansal D; Ray P
Indian J Cancer; 2014; 51(4):428-31. PubMed ID: 26842149
[TBL] [Abstract][Full Text] [Related]
46. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
[TBL] [Abstract][Full Text] [Related]
47. Changing bacterial isolates and antibiotic sensitivities of purulent dacryocystitis.
Briscoe D; Rubowitz A; Assia EI
Orbit; 2005 Jun; 24(2):95-8. PubMed ID: 16191795
[TBL] [Abstract][Full Text] [Related]
48. Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit.
Cumpston A; Craig M; Hamadani M; Abraham J; Hobbs GR; Sarwari AR
Transpl Infect Dis; 2013 Apr; 15(2):142-9. PubMed ID: 23279656
[TBL] [Abstract][Full Text] [Related]
49. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
Ardura MI; Mejías A; Katz KS; Revell P; McCracken GH; Sánchez PJ
Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
[TBL] [Abstract][Full Text] [Related]
50. Enteric gram-negative bacilli bloodstream infections: 17 years' experience in a neonatal intensive care unit.
Cordero L; Rau R; Taylor D; Ayers LW
Am J Infect Control; 2004 Jun; 32(4):189-95. PubMed ID: 15175611
[TBL] [Abstract][Full Text] [Related]
51. New antibiotic agents for bloodstream infections.
Vergidis PI; Falagas ME
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S60-5. PubMed ID: 18723329
[TBL] [Abstract][Full Text] [Related]
52. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia.
Lehrnbecher T; Venzon D; de Haas M; Chanock SJ; Kühl J
Clin Infect Dis; 1999 Aug; 29(2):414-9. PubMed ID: 10476751
[TBL] [Abstract][Full Text] [Related]
53. Empiric antibiotic protocols for cancer patients with neutropenia: a single-center study of treatment efficacy and mortality in patients with bacteremia.
Kleinhendler E; Cohen MJ; Moses AE; Paltiel O; Strahilevitz J; Cahan A
Int J Antimicrob Agents; 2018 Jan; 51(1):71-76. PubMed ID: 28705670
[TBL] [Abstract][Full Text] [Related]
54. Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours.
Marin M; Gudiol C; Ardanuy C; Garcia-Vidal C; Calvo M; Arnan M; Carratalà J
J Infect; 2014 Nov; 69(5):417-23. PubMed ID: 24960295
[TBL] [Abstract][Full Text] [Related]
55. [Neutropenia and sepsis in hematologic patients].
Egyed M; Kollár B; Karádi E; Rajnics P; Kocsondi L; Rumi G
Orv Hetil; 2006 Oct; 147(42):2031-3. PubMed ID: 17165603
[TBL] [Abstract][Full Text] [Related]
56. Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients.
Shelburne SA; Lasky RE; Sahasrabhojane P; Tarrand JT; Rolston KV
Clin Infect Dis; 2014 Jul; 59(2):223-30. PubMed ID: 24755857
[TBL] [Abstract][Full Text] [Related]
57. Longitudinal surveillance of bacteraemia in haematology and oncology patients at a UK cancer centre and the impact of ciprofloxacin use on antimicrobial resistance.
Schelenz S; Nwaka D; Hunter PR
J Antimicrob Chemother; 2013 Jun; 68(6):1431-8. PubMed ID: 23396855
[TBL] [Abstract][Full Text] [Related]
58. [The spectrum of pathogens in positive blood cultures--Tyrol 1991].
Allerberger F; Schneidinger M; Neher C; Brezinka C; Guggenbichler JP; Dierich MP
Wien Med Wochenschr; 1992; 142(17):385-9. PubMed ID: 1481545
[TBL] [Abstract][Full Text] [Related]
59. Does HIV status affect the aetiology, bacterial resistance patterns and recommended empiric antibiotic treatment in adult patients with bloodstream infection in Cambodia?
Phe T; Vlieghe E; Reid T; Harries AD; Lim K; Thai S; De Smet B; Veng C; Kham C; Ieng S; van Griensven J; Jacobs J
Trop Med Int Health; 2013 Apr; 18(4):485-94. PubMed ID: 23294446
[TBL] [Abstract][Full Text] [Related]
60. Empiric combination therapy for gram-negative bacteremia.
Sick AC; Tschudin-Sutter S; Turnbull AE; Weissman SJ; Tamma PD
Pediatrics; 2014 May; 133(5):e1148-55. PubMed ID: 24709936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
